Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
32.49
+4.69 (16.87%)
At close: Sep 4, 2025, 4:00 PM
32.49
0.00 (0.00%)
Pre-market: Sep 5, 2025, 6:13 AM EDT
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $98.84 million as of September 5, 2025. Its market cap has increased by 2,116.43% in one year.
Market Cap
98.84M
Enterprise Value
101.08M
1-Year Change
2,116.43%
Ranking
Category
Stock Price
$32.49
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $98.84M, an increase of 257.03%. That is a compound annual growth rate of 127.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 98.84M | 2,457.98% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |